только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 19 / 19
Страница 27 / 27

Глава 16. Рубцы

Внимание! Часть функций, например, копирование текста к себе в конспект, озвучивание и т.д. могут быть доступны только в режиме постраничного просмотра.Режим постраничного просмотра
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Draaijers L.J., Botman Y.A., Tempelman F.R. et al. Skin elasticity meter or subjective evaluation in scars: a reliability assessment // Burns. 2004. Vol. 30. N. 2. P. 109–114. DOI: https://doi.org/10.1016/j.burns.2003.09.003.

Ellis M.M., Jones L.R., Siddiqui F. et al. The efficacy of surgical excision plus adjuvant multimodal therapies in the treatment of keloids: a systematic review and meta-analysis // Dermatol. Surg. 2020. Vol. 46. N. 8. P. 1054–1059. DOI: https://doi.org/10.1097/DSS.0000000000002362.

Ellitsgaard V., Ellitsgaard N. Hypertrophic scars and keloids: a recurrent problem revisited // Acta Chir. Plast. 1997. Vol. 39. N. 3. P. 69–77.

Esposito G., Ziccardi P., Scioli M. et al. The use of a modified tonometer in burn scar therapy // J. Burn Care Rehabil. 1990. Vol. 11. N. 1. P. 86–90.

Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU // Dermatol. Surg. 1999. Vol. 25. P. 224–232.

Friedman S.J., Butler D.F., Pittelkow M.R. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature // J. Am. Acad. Dermatol. 1988. Vol. 19. N. 3. P. 537–541. DOI: https://doi.org/10.1016/s0190-9622(88)70209-1. PMID: 3049699.

Ginsberg B.A., Calderon M., Seminara N.M., Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community // J. Am. Acad. Dermatol. 2016. Vol. 74. P. 303–308.

Gold M.H. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids // J. Am. Acad. Dermatol. 1994. Vol. 30. N. 3. P. 506–507. DOI: https://doi.org/10.1016/s0190-9622(08)81956-1. PMID: 8113473.

Goldan O., Weissman O., Regev E. et al. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections // Aesthetic Plast. Surg. 2008. Vol. 32. N. 2. P. 389–392. DOI: https://doi.org/10.1007/s00266-007-9109-3. PMID: 18185952.

Goldman M.P., Fitzpatrick R.E. Laser treatment of scars // Dermatol. Surg. 1995. Vol. 21. N. 8. P. 685–687.

Granstein R.D., Rook A., Flotte T.J. et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings // Arch. Dermatol. 1990. Vol. 126. N. 10. P. 1295–1302. PMID: 2121104.

Gupta S., Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids // Dermatology. 2002. Vol. 204. N. 2. P. 130–132. DOI: https://doi.org/10.1159/000051830.

Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring: a classification system and review of treatment options // J. Am. Acad. Dermatol. 2001. Vol. 45. N. 1. P. 109–117.

Jordan R.B., Daher J., Wasil K. Splints and scar management for acute and reconstructive burn care // Clin. Plast. Surg. 2000. Vol. 27. N. 1. P. 71–85. PMID: 10665357.

Kantor J. Reliability and photographic equivalency of the scar cosmesis assessment and rating (scar) scale, an outcome measure for postoperative scars // JAMA Dermatol. 2017. Vol. 153. N. 1. P. 55–60. DOI: https://doi.org/10.1001/jamadermatol.2016.3757.

Katz B.E. Silicone gel sheeting in scar therapy // Cutis. 1995. Vol. 56. N. 1. P. 65–67. PMID: 7555106.

Kischer C.W., Shetlar M.R., Shetlar C.L., Chvapil M. Immunoglobulins in hypertrophic scars and keloids // Plast. Reconstr. Surg. 1983. Vol. 71. N. 6. P. 821–825.

Koonin A.J. The aetiology of keloids: a review of the literature and a new hypothesis // S. Afr. Med. J. 1964. Vol. 38. P. 913–916.

Lawrence W.T. In search of the optimal treatment of keloids: report of a series and a review of the literature // Ann. Plast. Surg. 1991. Vol. 27. N. 2. P. 164–178. DOI: https://doi.org/10.1097/00000637-199108000-00012.

Mancini R.E., Quaife J.V. Histogenesis of experimentally produced keloids // J. Invest. Dermatol. 1962. Vol. 38. P. 143–181.

Mankowski P., Kanevsky J., Tomlinson J. et al. Optimizing radiotherapy for keloids: a meta-analysis systematic review comparing recurrence rates between different radiation modalities // Ann. Plast. Surg. 2017. Vol. 78. N. 4. P. 403–411. DOI: https://doi.org/10.1097/SAP.0000000000000989.

Manuskiatti W., Fitzpatrick R.E. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments // Arch. Dermatol. 2002. Vol. 138. N. 9. P. 1149–1155. DOI: https://doi.org/10.1001/archderm.138.9.1149. PMID: 12224975.

Monstrey S., Middelkoop E., Vranckx J.J. et al. Updated scar management practical guidelines: non-invasive and invasive measures // J. Plast. Reconstr. Aesthet. Surg. 2014. Vol. 67. N. 8. P. 1017–1025. DOI: https://doi.org/10.1016/j.bjps.2014.04.011. Epub 2014 May 14. PMID: 24888226.

Moustafa M.F., Abdel-Fattah M.A., Abdel-Fattah D.C. The presumptive of the presumptive evidence of pregnancy estrogen on keloid growth: case report // Plast. Reconstr. Surg. 1975. Vol. 56. N. 4. P. 450–453.

Mustoe T.A., Cooter R.D., Gold M. et al. International clinical recommendations on scar management // Plast. Reconstr. Surg. 2002. Vol. 110. N. 2. P. 560–571.

Nakashima M., Chung S., Takahashi A. et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population // Nat. Genet. 2010. Vol. 42. N. 9. P. 768–771. DOI: https://doi.org/10.1038/ng.645.

Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis // Int. J. Mol. Sci. 2017. Vol. 18. N. 3. P. 606. DOI: https://doi.org/10.3390/ijms18030606.

Ogawa R., Mitsuhashi K., Hyakusoku H., Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months // Plast. Reconstr. Surg. 2003. Vol. 111. N. 2. P. 547–553.

Omo-Dare P. Yoruban contributions to the literature on keloids // J. Natl Med. Assoc1973. Vol. 65. N. 5. P. 367–406.

Robert R., Meyer W., Bishop S. et al. Disfiguring burn scars and adolescent self-esteem // Burns. 1999. Vol. 25. N. 7. P. 581–585. DOI: https://doi.org/10.1016/s0305-4179(99)00065-0.

Roques C., Teot L., Frasson N., Meaume S. PRIMOS: an optical system that produces three- dimensional measurements of skin surfaces // J. Wound Care. 2003. Vol. 12. N. 9. P. 362–364.

Roseborough I.E., Grevious M.A., Lee R.C. Prevention and treatment of excessive dermal scarring // J. Natl Med. Assoc. 2004. Vol. 96. N. 1. P. 108–116.

Rusciani L., Rossi G., Bono R. Use of cryotherapy in the treatment of keloids // J. Dermatol. Surg. Oncol. 1993. Vol. 19. N. 6. P. 529–534. DOI: https://doi.org/10.1111/j.1524-4725.1993.tb00386.x. PMID: 8509514.

Shaheen A., Khaddam J., Kesh F. Risk factors of keloids in Syrians // BMC Dermatol. 2016. Vol. 16. N 1. P. 13. DOI: https://doi.org/10.1186/s12895-016-0050-5.

Shin J.Y., Lee J.W., Roh S.G. et al. A comparison of the effectiveness of triamcinolone and radiation therapy for ear keloids after surgical excision: a systematic review and meta-analysis // Plast. Reconstr. Surg. 2016. Vol. 137. N. 6. P. 1718–1725. DOI: https://doi.org/10.1097/PRS.0000000000002165. PMID: 27219228.

Sproat J.E., Dalcin A., Weitauer N., Roberts R.S. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment // Plast. Reconstr. Surg. 1992. Vol. 90. N. 6. P. 988–992. PMID: 1448534.

Steinbrech D.S., Mehrara B.J., Chau D. et al. Hypoxia upregulates VEGF production in keloid fibroblasts // Ann. Plast. Surg. 1999. Vol. 42. N. 5. P. 514–519.

Sun L.M., Wang K.H., Lee Y.C. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study // Arch. Dermatol. Res. 2014. Vol. 306. N. 9. P. 803–808. DOI: https://doi.org/10.1007/s00403-014-1491-5.

Thorn I. Ueber spontanes keloid // Arch. Klin. Chir. 1895. Vol. 51. P. 618–636.

Tredget E.E., Wang R., Shen Q. et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo // J. Interferon Cytokine Res. 2000. Vol. 20. N. 2. P. 143–151. DOI: https://doi.org/10.1089/107999000312540. PMID: 10714549.

Unna PG. The Histopathology of the Diseases of the Skin. New York: Macmillan, 1896. 1205 p.

Van de Kar A.L., Kreulen M., van Zuijlen P.P., Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: a prospective clinical outcome study // Plast. Reconstr. Surg. 2007. Vol. 119. N. 7. P. 2248–2254.

Weinhammer A.P., Shields B.E., Keenan T. Intralesional corticosteroid-induced hypopigmentation and atrophy // Dermatol Online J. 2020. Vol. 26. N. 1. Article ID 13030/qt0bj81707. PMID: 32155037.

Yeong E.K., Mann R., Engrav L.H. et al. Improved burn scar assessment with use of a new scar-rating scale // J. Burn Care Rehabil. 1997. Vol. 18. P. 353–355.

Young V.L., Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys // Plast. Reconstr. Surg. 2009. Vol. 124. N. 1. P. 256–265. DOI: https://doi.org/10.1097/PRS.0b013e3181a80747.